HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expression-Reference-Cited by-同舟云学术

HLA-DR-negative AML (M1 and M2): FLT3 mutations (ITD and D835) and cell-surface antigen expression

Published:2007-07 Issue:7 Volume:31 Page:921-929
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Syampurnawati Meilani,Tatsumi Eiji,Furuta Kaho,Takenokuchi Mariko,Nakamachi Yuji,Kawano Seiji,Kumagai Shunichi,Saigo Katsuyasu,Matsui Toshimitsu,Takahashi Takayuki,Nagai Ken-ichi,Yabe Hiroki,Kondo Shinichi,Hayashi Yoshitake

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference29 articles.

1. The immunophenotype of acute promyelocytic leukemia (APL): an ECOG study;Paietta;Leukemia,1994

2. A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes;Paietta;Cytometry B Clin Cytom,2004

3. HLA-DR antigen-negative acute myeloid leukemia;Wetzler;Leukemia,2003

4. Flow cytometric analysis of acute leukemias: diagnostic utility and critical analysis of data;Kaleem;Arch Pathol Lab Med,2003

5. HLA-Dr negative acute non-lymphocytic leukemia;Lazarchick;Ann Clin Lab Sci,1998

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the intricate cross-talk between clonal expansion and the bone marrow niche;Frontiers in Hematology;2024-03-01

2. CD34 negative HLA‐DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3‐ITD mutations;International Journal of Laboratory Hematology;2022-12-11

3. MRD abnormal expression predict poor outcomes for refractory or relapsed acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation;Journal of Clinical Laboratory Analysis;2021-08-25

4. High incidence of FLT3 mutations in follicular thyroid cancer: potential therapeutic target in patients with advanced disease stage;Therapeutic Advances in Medical Oncology;2020-01

5. Differential requirements for myeloid leukemia IFN-γ conditioning determine graft-versus-leukemia resistance and sensitivity;Journal of Clinical Investigation;2017-06-12